机译:剂量发现和疗效确认试验顺铂的超重动脉内输注和伴随放疗当地先进的上颌窦癌(日本临床肿瘤组1212):剂量发现阶段
Department of Otolaryngology ‐ Head and Neck Surgery Faculty of Medicine and Graduate School of;
Department of Radiation Medicine Faculty of Medicine and Graduate School of MedicineHokkaido;
Division of Head and Neck Surgery Miyagi Cancer CenterSendai Japan;
Department of Otolaryngology ‐ Head and Neck SurgeryKobe University Graduate School of MedicineKobe;
Department of Otolaryngology ‐ Head and Neck Surgery Faculty of Medicine and Graduate School of;
Department of Head and Neck SurgeryIwate Medical University School of MedicineMorioka Japan;
Department of Radiation OncologyAichi Cancer Center HospitalNagoya Japan;
Japan Clinical Oncology Group Data Center/Operations Office National Cancer CenterTokyo Japan;
Japan Clinical Oncology Group Data Center/Operations Office National Cancer CenterTokyo Japan;
Japan Clinical Oncology Group Data Center/Operations Office National Cancer CenterTokyo Japan;
Japan Clinical Oncology Group Data Center/Operations Office National Cancer CenterTokyo Japan;
Japan Clinical Oncology Group Data Center/Operations Office National Cancer CenterTokyo Japan;
Department of OtolaryngologyNational Hospital Organization Tokyo Medical CenterTokyo Japan;
Division of Head and Neck Surgery National Cancer Center Hospital EastKashiwa Japan;
chemoradiotherapy; cisplatin; intra‐arterial; maxillary sinus cancer; squamous cell carcinoma;
机译:剂量发现和疗效确认试验顺铂的超重动脉内输注和伴随放疗当地先进的上颌窦癌(日本临床肿瘤组1212):剂量发现阶段
机译:超选择性动脉内顺铂输注及放射疗法治疗上颌窦癌
机译:使用超选动脉内顺铂和伴随辐射治疗上颌窦局部晚期鳞状细胞癌的局部晚期鳞状细胞癌:对预后因素的影响
机译:在I期临床研究中将最大耐受剂量应用于IL-21 Denenicokin的最大范例
机译:超选择性动脉内顺铂输注及放射疗法治疗上颌窦癌
机译:总辐射剂量对放疗中治疗结果的影响及伴随的颌动脉内部高剂量顺铂治疗局部晚期上颌窦癌